Analyst coverage & consensus

Analyst Consensus Banner

Disclaimer

Helios Towers plc is covered by research analysts at seven registered investment research firms: BofA Securities, Berenberg, Citi Research, Deutsche Numis, Jefferies, Morgan Stanley and New Street. 

These forecasts are not endorsed by Helios Towers plc, nor does Helios Towers plc assume any obligation to update or revise the consensus to reflect circumstances arising after the date below.

This consensus has been compiled by Helios Towers plc as of the 16th March 2026 and excludes estimates published prior to 7th November 2025. Firms contributing to the full-year consensus were: Berenberg, BofA Securities, Citi Research, Deutsche Numis, Morgan Stanley and Jefferies.

Analyst consensus

(In US$m, unless indicated otherwise) FY2026 FY2027 FY2028
Mean High Low Mean High Low Mean High Low
Sites (#) 15,281 15,325 15,191 15,772 15,985 15,541 16,240 16,645 15,841
Tenancies (#) 34,308 34,620 34,102 36,528 37,140 36,114 38,653 39,520 37,987
Adj. EBITDA(1) 520.9 523.0 517.5 574.3 581.0 569.7 628.3 640.9 621.0
RFCF(2) 215.0 222.1 209.1 246.2 251.2 240.4 281.6 293.4 269.7
Disc. Capex(3) 123.9 129.7 117.3 118.3 133.3 110.3 116.6 137.3 107.9

 

Analyst coverage

Institution Name Contact details Last update Recommendation Price target
BofA Securities David Wright

dawright@bofa.com

+44 20 7995 6355

12/03/2026 Buy 236
Berenberg Alex Short

 Alexander.Short@berenberg.com

+44 20 3753 3068

12/03/2026 Buy 230
Citi Research Rohit Modi

rohit1.modi@citi.com

+44 20 7508 1081

17/11/2025 Buy 200
Deutsche Numis John Karidis

john.karidis@db.com

+44 20 7260 1311

16/03/2026 Buy 270
Jefferies Graham Hunt

ghunt@jefferies.com 

+ 44 20 7548 4251

12/03/2026 Buy 254
Morgan Stanley Emmet Kelly

emmet.kelly@morganstanley.com

+44 20 7425 6830

30/01/2026 Overweight 230
New Street Chris Hoare

chris@newstreetresearch.com

+44 20 7375 9130

29/09/2025 Buy 180

 

(1) Adjusted EBITDA is defined as loss for the period, adjusted for tax expenses, finance costs, gain/(loss) on derivative financial instruments, interest receivable, loss on disposal of property, plant and equipment, amortisation of intangible assets, depreciation and impairment of property, plant and equipment, depreciation of right-of-use assets, recharged depreciation, deal costs, share-based payments and long-term incentive plan charges, and exceptional items. Exceptional items are material items that are considered exceptional in nature by management by virtue of their size and/or incidence.

(2) RFCF - Recurring free cash flow (RFCF) is defined as a measure of the Company’s cash flow generation available for (i) discretionary capital expenditure, and other exceptional items, and (ii) capital providers and investor distributions.

(3) Disc Capex -Discretionary includes acquisitions, growth and upgrade capex.